3i’s withdrawal seen as having limited impact on early-stage companies

The decision of 3i, one of Britain’s largest private equity firms, to stop investing in start-ups and early-stage companies will reduce the financing options for a number of small companies. But the amount of money involved is relatively small compared with 3i’s total assets under management, the company said.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom